H.C. Wainwright Starts Seres Therapeutics (MCRB) at Buy
(Updated - June 23, 2026 6:48 AM EDT)
H.C. Wainwright analyst Matthew Keller initiates coverage on Seres Therapeutics (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
H.C. Wainwright analyst Matthew Keller initiates coverage on Seres Therapeutics (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
